Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MGRX compared with DVA: revenue, margins and what each company keeps, and the suppliers and customers both name
MGRX
Mangoceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
DVA
DaVita Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MGRX
Mangoceuticals, Inc.
vs
DVA
DaVita Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
MGRX
Mangoceuticals, Inc.
Change
0.23
▲
+7.71%
· post 0.21
Mkt cap
$4.5M
Revenue
$68,757
Q2 FY26
Revenue
$456,021
FY25
DVA
DaVita Inc.
Change
192.63
▲
+5.74%
· post 190.75
Closed
Nov 4 '26
Mkt cap
$11.5B
Revenue
$3.6B
Q3 FY26
Revenue
$13.6B
FY25
vs
Compare
Closed
Nov 4 '26
MGRX
Mangoceuticals, Inc.
vs
DVA
DaVita Inc.
0.23
▲
+7.71%
post 0.21
Price
192.63
▲
+5.74%
post 190.75
$4.5M
Mkt cap
$11.5B
Q2 FY26
$68,757
Revenue
$3.6B
Q3 FY26
FY25
$456,021
Revenue
$13.6B
FY25
Change
Change
MGRX
0.23
▲
+7.71%
vs
DVA
192.63
▲
+5.74%
Closed
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MGRX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MGRX
0
None
Shared
0
No disclosed counterparties: MGRX.
Only DVA
8
CHCT
Community Healthcare Trust
supplier
AKBA
Akebia Therapeutics
supplier
RMTI
Rockwell Medical
supplier
—
Change Healthcare (CHC)
unlisted
supplier
4 more · DVA chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MGRX, solid
DVA, dashed